Aktis Oncology

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

$175M

Aktis Oncology is a clinical-stage biotechnology company developing a proprietary radiopharmaceutical pipeline, including Nectin-4-targeted miniprotein radioconjugates, for cancer treatment.